EnWave Initiates Transfer of Commercial-Scale powderREV(R) Machine to Major North American Enzyme Producer

EnWave Initiates Transfer of Commercial-Scale powderREV(R) Machine to Major 
North American Enzyme Producer 
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/18/14 -- EnWave
Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the
"Company") announced today that the Company has initiated the
transfer of a commercial-scale powderREV(R) machine (the "Machinery")
to the major North American enzyme producer (the "Enzyme Producer")
who signed a royalty-bearing commercial license to use Radiant Energy
Vacuum ("REV(TM)") technology in April 2013. Prior to the initiation
of the transfer, EnWave completed successful in-house dehydration
trials for several enzyme solutions. 
EnWave will now begin installation of the machine at the Enzyme
Producer's site in preparation for initial testing to begin toward
the beginning of April. Complications relating to the Enzyme
Producer's site preparation delayed the timing of the delivery and
the customer verification work which needs to be completed with their
established Tier 1 customers prior to commercialization. If the
customer verification is successful the Enzyme Producer and EnWave
have now targeted the second half of 2014 for commercial start-up of
the Machinery. The Enzyme Producer is expected to produce several
dehydrated enzymes used in a number of food related applications and
has secured an option for another enzyme category should the
technology successfully meet commercial targets.  
powderREV(R) is designed with the goal of accelerating the drying
times of biomaterials below freezing, while reducing production costs
and maintaining high efficacy of the end product. Within the existing
License Agreement, EnWave has the right to showcase the commercial
powderREV(R) plant to other potential licensees in the future. The
Enzyme industry is a large diverse growing global market that
produces applications for food products, detergents, teeth-whitening
products, biofuels and other health improvement areas. The Company
hopes to further penetrate this market after demonstrating initial
commercial success. 
"The interest in our commercial-scale powderREV(R) technology is at
an all-time high," stated Dr. Tim Durance, Chairman & Co-CEO. "We are
focused on doing everything in our power to expedite the start-up
process, which when completed will allow EnWave to showcase the
Machinery to other potential customers." 
About EnWave  
EnWave Corporation is a Vancouver-based industrial technology company
developing commercial applications for its proprietary Radiant Energy
Vacuum (REV(TM)) dehydration technology. EnWave aims to sign
royalty-bearing commercial licenses with leading food and
pharmaceutical companies for the use of its revolutionary technology.
Thus far the Company has signed commercial licenses with Bonduelle, a
global leader in the production of vegetables, for the processing of
dehydrofrozen vegetables; Hormel Foods Corporation, a major processed
meat manufacturer, for the production of healthy dried meat products;
Milne Fruit Product, EnWave's first major licensee, for the
production of several dehydrated fruit and vegetable products in the
whole, fragmented and powdered form; a leading North American enzyme
company, to dehydrate a series of food-related enzymes for their Tier
1 clients; and Napa Mountain Spice Company, to dry high-quality
California bay leaves. In addition to these licenses, EnWave has
formed a Limited Liability Partnership with Lucid Capital Management
to develop, manufacture, market and sell all-natural cheese snack
products in the United States under the Moon Cheese(R) brand.  
Also, EnWave has entered into a wide range of research and
collaboration agreements with an expanding list of multinational
companies, including Nestle, Kellogg's, Grupo Bimbo, Grimmway Farms,
Ocean Spray Cranberries, Cherry Central, Sun-Maid Growers, Gay Lea
Foods, R.J. Reynolds and Merck. EnWave is introducing REV(TM) as a
new dehydration standard in the food and biological material sectors:
potentially faster and cheaper than freeze drying, with better end
product quality than air drying or spray drying. 
EnWave currently has six REV(TM) platforms: commercial-scale
nutraREV(R) and MIVAP(R) are used in the food industry to dry fruits,
vegetables, meat, herbs and seafood quickly and at low-cost, while
maintaining high levels of nutrition, taste, texture and colour. The
Company is also developing powderREV(TM) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes;
quantaREV(TM) for continuous, high-volume low-temperature drying of
pastes, gels, liquids, or particulates; and bioREV(TM) and
freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information
about EnWave is available at www.enwave.net.  
EnWave Corporation 
Dr. Tim Durance, Chairman & Co-CEO 
Safe Harbour for Forward-Looking Information Statements: This press
release may contain forward-looking information based on management's
expectations, estimates and projections. All statements that address
expectations or projections about the future, including statements
about the Company's strategy for growth, product development, market
position, expected expenditures, and the expected synergies following
the closing are forward-looking statements. All third party
references to market information in this release are not guaranteed
to be accurate as the Company did not conduct the original primary
research. These statements are not a guarantee of future performance
and involve a number of risks, uncertainties and assumptions.
Although the Company has attempted to identify important factors that
could cause actual results to differ materially, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements. 
Neither the TSX Venture Exchange nor its Regulation Services Provider
(as that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
Contacts:
EnWave Corporation
Mr. John McNicol
President & Co-CEO
(604)601-8524
john.mcnicol@enwave.net 
EnWave Corporation
Mr. Brent Charleton
Vice President, Corporate Affairs
(778)378-9616
bcharleton@enwave.net
www.enwave.net
 
 
Press spacebar to pause and continue. Press esc to stop.